133 related articles for article (PubMed ID: 33903995)
1. The Seven STAT3-Related Hyper-IgE Syndromes.
Fadil I; Ben-Ali M; Jeddane L; Barbouche MR; Bousfiha AA
J Clin Immunol; 2021 Aug; 41(6):1384-1389. PubMed ID: 33903995
[No Abstract] [Full Text] [Related]
2. Two Prenatal Cases of Hyper-IgE Syndrome.
Egawa M; Imai K; Taketani Y; Morio T; Miyasaka N
J Clin Immunol; 2019 Jan; 39(1):15-18. PubMed ID: 30617622
[No Abstract] [Full Text] [Related]
3. Invasive fungal disease in autosomal-dominant hyper-IgE syndrome.
Vinh DC; Sugui JA; Hsu AP; Freeman AF; Holland SM
J Allergy Clin Immunol; 2010 Jun; 125(6):1389-90. PubMed ID: 20392475
[TBL] [Abstract][Full Text] [Related]
4. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.
Siegel AM; Stone KD; Cruse G; Lawrence MG; Olivera A; Jung MY; Barber JS; Freeman AF; Holland SM; O'Brien M; Jones N; Nelson CG; Wisch LB; Kong HH; Desai A; Farber O; Gilfillan AM; Rivera J; Milner JD
J Allergy Clin Immunol; 2013 Dec; 132(6):1388-96. PubMed ID: 24184145
[TBL] [Abstract][Full Text] [Related]
5. Omalizumab in the Treatment of Hyper-IgE Syndrome: 2 Case Reports.
Gomes N; Miranda J; Lopes S; Carneiro-Leão L; Torres Costa J; Baudrier T; Azevedo F
J Investig Allergol Clin Immunol; 2020; 30(3):191-192. PubMed ID: 31820738
[No Abstract] [Full Text] [Related]
6. Hyper-IgE syndromes: reviewing PGM3 deficiency.
Yang L; Fliegauf M; Grimbacher B
Curr Opin Pediatr; 2014 Dec; 26(6):697-703. PubMed ID: 25365149
[TBL] [Abstract][Full Text] [Related]
7. Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China.
Xie L; Hu X; Li Y; Zhang W; Chen L
Clin Dev Immunol; 2010; 2010():289873. PubMed ID: 20490271
[TBL] [Abstract][Full Text] [Related]
8. Novel STAT3 mutation causing hyper-IgE syndrome: studies of the clinical course and immunopathology.
Sundin M; Tesi B; Sund Böhme M; Bryceson YT; Pütsep K; Chiang SC; Thunberg S; Winiarski J; Wikström AC
J Clin Immunol; 2014 May; 34(4):469-77. PubMed ID: 24627079
[TBL] [Abstract][Full Text] [Related]
9. Hyper-IgE syndrome with a novel mutation of the STAT3 gene.
Minakawa S; Tanaka H; Kaneko T; Matsuzaki Y; Kono M; Akiyama M; Minegishi Y; Sawamura D
Clin Exp Dermatol; 2016 Aug; 41(6):687-9. PubMed ID: 27333819
[No Abstract] [Full Text] [Related]
10. Impaired memory B-cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper-IgE syndrome.
van de Veen W; Krätz CE; McKenzie CI; Aui PM; Neumann J; van Noesel CJM; Wirz OF; Hagl B; Kröner C; Spielberger BD; Akdis CA; van Zelm MC; Akdis M; Renner ED
Allergy; 2019 Dec; 74(12):2394-2405. PubMed ID: 31269238
[TBL] [Abstract][Full Text] [Related]
11. Hyper IgE syndromes: clinical and molecular characteristics.
Al-Shaikhly T; Ochs HD
Immunol Cell Biol; 2019 Apr; 97(4):368-379. PubMed ID: 30264496
[TBL] [Abstract][Full Text] [Related]
12. A novel STAT3 mutation in a patient with hyper-immunoglobulin E syndrome.
Ovadia A; Kessel A; Leshinsky-Silver E; Dalal I
Isr Med Assoc J; 2015 Jan; 17(1):62-3. PubMed ID: 25739182
[No Abstract] [Full Text] [Related]
13. Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation.
Kumánovics A; Perkins SL; Gilbert H; Cessna MH; Augustine NH; Hill HR
J Clin Immunol; 2010 Nov; 30(6):886-93. PubMed ID: 20859667
[TBL] [Abstract][Full Text] [Related]
14. Autosomal Dominant Hyper-IgE Syndrome Without Significantly Elevated IgE.
Larsen CS; Christiansen M; Mogensen TH
J Clin Immunol; 2019 Nov; 39(8):827-831. PubMed ID: 31468318
[No Abstract] [Full Text] [Related]
15. Hyper-IgE syndrome.
Rezaei N; Aghamohammadi A
J Postgrad Med; 2010; 56(2):63-4. PubMed ID: 20622381
[No Abstract] [Full Text] [Related]
16. B-cell-specific STAT3 deficiency: Insight into the molecular basis of autosomal-dominant hyper-IgE syndrome.
Kane A; Lau A; Brink R; Tangye SG; Deenick EK
J Allergy Clin Immunol; 2016 Nov; 138(5):1455-1458.e3. PubMed ID: 27423495
[No Abstract] [Full Text] [Related]
17. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis.
Tavassoli M; Abolhassani H; Yazdani R; Ghadami M; Azizi G; Abdolrahim Poor Heravi S; Moeini Shad T; Kokabee M; Movahedi M; Abdshahzadeh H; Gharagozlou M; Rezaei N; Esmaeilzadeh H; Aleyasin S; Aghamohammadi A
Pediatr Allergy Immunol; 2019 Jun; 30(4):469-478. PubMed ID: 30801830
[TBL] [Abstract][Full Text] [Related]
18. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
19. Clinical manifestations of hyper IgE syndromes.
Freeman AF; Holland SM
Dis Markers; 2010; 29(3-4):123-30. PubMed ID: 21178271
[TBL] [Abstract][Full Text] [Related]
20. An Unexpected Infection in Loss-of-Function Mutations in STAT3: Malignant Alveolar Echinococcosis in Liver.
Haskologlu S; Dogu F; Gollu Bahadır G; Akyuzluer S; Ciftci E; Altun D; Keles S; Kologlu M; Ikinciogullari A
Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):667-675. PubMed ID: 33463136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
